| 1 |
35455696 | The Influence of the CES1 Genotype on the Pharmacokinetics of Enalapril in Patients with Arterial Hypertension. | 2022 Apr 5 |
1 |
| 2 |
32766265 | Measurement of Bradykinin Formation and Degradation in Blood Plasma: Relevance for Acquired Angioedema Associated With Angiotensin Converting Enzyme Inhibition and for Hereditary Angioedema Due to Factor XII or Plasminogen Gene Variants. | 2020 |
2 |
| 3 |
33218024 | Target-Centered Drug Repurposing Predictions of Human Angiotensin-Converting Enzyme 2 (ACE2) and Transmembrane Protease Serine Subtype 2 (TMPRSS2) Interacting Approved Drugs for Coronavirus Disease 2019 (COVID-19) Treatment through a Drug-Target Interaction Deep Learning Model. | 2020 Nov 18 |
1 |
| 4 |
30113034 | [Enalaprilat Inhibits Zinc-Dependent Oligomerization of Metal-Binding Domain of Amyloid-beta Isoforms and Protects Human Neuroblastoma Cells from Toxic Action of these Isoforms]. | 2018 Jul-Aug |
1 |
| 5 |
24639651 | Pharmacological evidence of bradykinin regeneration from extended sequences that behave as peptidase-activated B2 receptor agonists. | 2014 |
1 |
| 6 |
23404365 | A detailed physiologically based model to simulate the pharmacokinetics and hormonal pharmacodynamics of enalapril on the circulating endocrine Renin-Angiotensin-aldosterone system. | 2013 |
2 |
| 7 |
23647543 | Molecular recognition of human angiotensin-coverting enzyme I (hACE I) and different inhibitors. | 2013 |
1 |
| 8 |
23903258 | [Increase in lipophilicity of enalaprilat by complexation with copper(II) or zinc(II) Ions]. | 2013 |
1 |
| 9 |
21986309 | An in vitro reconstitution system to address the mechanism of the vascular expression of the bradykinin B₁ receptor in response to angiotensin converting enzyme inhibition. | 2012 Aug 19 |
1 |
| 10 |
23166630 | Conformational changes of blood ACE in chronic uremia. | 2012 |
2 |
| 11 |
20015194 | A novel pathway for receptor-mediated post-translational activation of inducible nitric oxide synthase. | 2011 Feb |
1 |
| 12 |
21646245 | Acute effects of the ACE inhibitor enalaprilat on the pulmonary, cerebral and systemic blood flow and resistance after the bidirectional cavopulmonary connection. | 2011 Aug |
1 |
| 13 |
21864683 | Met-Lys-bradykinin-Ser-Ser, a peptide produced by the neutrophil from kininogen, is metabolically activated by angiotensin converting enzyme in vascular tissue. | 2011 Nov |
1 |
| 14 |
20452384 | A ligand-based approach to investigate the expression and function of angiotensin converting enzyme in intact human umbilical vein endothelial cells. | 2010 Aug |
2 |
| 15 |
18816584 | Studies on the molecular recognition between bioactive peptides and angiotensin-converting enzyme. | 2009 Mar-Apr |
1 |
| 16 |
18201802 | Lack of direct interaction between enalaprilat and the kinin B1 receptors. | 2008 Apr |
3 |
| 17 |
18399693 | Accurate aqueous proton dissociation constants calculations for selected angiotensin-converting enzyme inhibitors. | 2008 Jun |
1 |
| 18 |
16282523 | Angiotensin I-converting enzyme inhibitors block protein kinase C epsilon by activating bradykinin B1 receptors in human endothelial cells. | 2006 Mar |
2 |
| 19 |
15475593 | Kinin peptides in human trapezius muscle during sustained isometric contraction and their relation to pain. | 2005 Feb |
2 |
| 20 |
15883972 | Domain-selective ligand-binding modes and atomic level pharmacophore refinement in angiotensin I converting enzyme (ACE) inhibitors. | 2005 Jun |
1 |
| 21 |
16148375 | [Angiotensin-converting enzyme inhibitor treatment of heart failure due to dilated cardiomyopathy]. | 2005 Jul-Aug |
1 |
| 22 |
14743484 | Determination of the cis-trans isomerization barrier of enalaprilat by dynamic capillary electrophoresis and computer simulation. | 2004 Jan |
1 |
| 23 |
15236580 | Structural details on the binding of antihypertensive drugs captopril and enalaprilat to human testicular angiotensin I-converting enzyme. | 2004 Jul 13 |
3 |
| 24 |
15601445 | Pharmacokinetics and pharmacokinetic/pharmacodynamic relationships for angiotensin-converting enzyme inhibitors. | 2004 Dec |
2 |
| 25 |
12831415 | Effect of enalaprilat on postoperative hypertension after surgical repair of coarctation of the aorta. | 2003 Jul |
1 |
| 26 |
14511680 | Analysis of the isomeric composition of the proline peptide bond in an angiotensin-converting enzyme inhibitor using capillary electrophoresis. | 2003 Oct 15 |
1 |
| 27 |
14727943 | Hypertensive emergencies. Etiology and management. | 2003 |
1 |
| 28 |
11836639 | Endothelial function studies in pulmonary vascular disease: determination of angiotensin converting enzyme activity in humans (review). | 2002 Mar |
2 |
| 29 |
12489810 | Activation of a renin-angiotensin system in ischemic cardiac sympathetic nerve endings and its association with norepinephrine release. | 2002 Dec |
1 |
| 30 |
11393708 | Effect of column temperature on the behaviour of some angiotensin converting enzyme inhibitors during high-performance liquid chromatographic analysis. | 2001 May 5 |
1 |
| 31 |
11741551 | Effects of intracoronary low-dose enalaprilat as an adjunct to primary percutaneous transluminal coronary angiography in acute myocardial infarction. | 2001 Dec 15 |
2 |
| 32 |
10658731 | Angiotensin-converting enzyme inhibitor-enhanced phase-contrast MR imaging to measure renal artery velocity waveforms in patients with suspected renovascular hypertension. | 2000 Feb |
1 |
| 33 |
10710136 | The angiotensin-converting enzyme gene polymorphism and responses to angiotensins and bradykinin in the human forearm. | 2000 Mar |
1 |
| 34 |
10720592 | Functional importance of angiotensin-converting enzyme-dependent in situ angiotensin II generation in the human forearm. | 2000 Mar |
1 |
| 35 |
10852646 | Lisinopril: a review of its use in congestive heart failure. | 2000 May |
1 |
| 36 |
10874261 | Dissociation between ACE activity and autonomic response to ACE inhibition in patients with heart failure. | 2000 Jul |
2 |
| 37 |
11827728 | Quantification of pulmonary capillary endothelium-bound angiotensin converting enzyme inhibition in man. | 2000 Oct |
4 |
| 38 |
10082496 | Enhancement of bradykinin and resensitization of its B2 receptor. | 1999 Mar |
4 |
| 39 |
10087051 | Plasma levels of enalaprilat in chronic therapy of heart failure: relationship to adverse events. | 1999 Apr |
1 |
| 40 |
10096262 | Angiotensin-converting enzyme inhibition improves venous endothelial dysfunction in chronic smokers. | 1999 Mar |
2 |
| 41 |
10323266 | Expression, secretion, and inhibition of angiotensin-converting enzyme in cultured human bronchial epithelial cells. | 1999 Apr 9 |
1 |
| 42 |
10458510 | Des-Arg9-bradykinin metabolism in patients who presented hypersensitivity reactions during hemodialysis: role of serum ACE and aminopeptidase P. | 1999 |
1 |
| 43 |
10512591 | ACE inhibition and fibroblast growth factor in cultured human vascular smooth muscle. | 1999 |
1 |
| 44 |
10532602 | Anomaly of the des-Arg9-bradykinin metabolism associated with severe hypotensive reactions during blood transfusions: a preliminary study. | 1999 Oct |
4 |
| 45 |
10596866 | Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema. | 1999 Sep |
1 |
| 46 |
9620109 | Pharmacologic, pharmacokinetic, and therapeutic differences among ACE inhibitors. | 1998 May-Jun |
1 |
| 47 |
9802186 | Pharmacokinetic studies of enalaprilat in the in vitro perfused human placental lobule system. | 1998 Sep-Oct |
2 |
| 48 |
9815869 | ACE (I/D) genotype as a predictor of the magnitude and duration of the response to an ACE inhibitor drug (enalaprilat) in humans. | 1998 Nov 17 |
5 |
| 49 |
9822455 | Effects of acute ACE inhibition on pulsatile renin and aldosterone secretion and their synchrony. | 1998 Nov |
1 |
| 50 |
9860785 | Differential effects of quinaprilat and enalaprilat on endothelial function of conduit arteries in patients with chronic heart failure. | 1998 Dec 22-29 |
1 |